An Introduction to Devices
With improvements in technology and material science, devices are becoming an important component of the treatment paradigm for many cardiovascular conditions. Pacemakers are an established treatment option for patients with irregular heart rhythm. Increasing functionality such as MRI-safety, leadless options and automation have impacted patient experiences and outcomes. Stent technology is continuously evolving, with bioabsorbable-polymer drug-eluting stents and biodegradable stents being some of the most recent advances.
Browse the content below where leading experts discuss the latest data in video interviews and short articles from our conference hub, and browse the selection of peer-reviewed articles from our journal portfolio.
Our supporting partners do not constitute an endorsement of the content on this page.
Sem Briongos Figuero, EHRA 2023: The OptiVALL study, assessing the Micra AV device for atrioventricular synchronous pacing
The OptiVALL study aimed to assess the atrioventricular synchronous pacing capabilities of the Micra AV device, and to describe what programming changes are needed. In this touchCARDIO interview, we speak with Dr Sem Briongos Figuero (Hospital Infanta Leonor, Madrid, Spain) to discuss the purpose, design and findings of the OptiVALL study, as well as the […]
Sem Briongos Figuero, EHRA 2023: Clinical trials studying atrioventricular synchronous pacing, and the limitations
The MARVEL 2 trial studied atrioventricular synchronous pacing in patients with a Micra leadless ventricular pacemaker. In this touchCARDIO interview, we speak with Dr Sem Briongos Figuero (Hospital Infanta Leonor, Madrid, Spain) to discuss the trials studying atrioventricular synchrony and their limitations. Sem Briongos Figuero presented an abstract entitled ‘Optimizing atrial sensing parameters in leadless […]
Gregg Stone, ACC 2023: Transcatheter edge-to-edge repair for functional mitral regurgitation in heart failure
Transcatheter edge-to-edge repair (TEER) is a minimally invasive procedure that can effectively treat functional mitral regurgitation in heart failure patients. Compared to traditional surgical approaches, TEER offers benefits such as reduced hospital stay, lower risk of bleeding and infection, and faster recovery time. Additionally, TEER has been found to improve symptoms and quality of life […]
Andrew Krahn: Heart Rhythm 2023 & HRX 2023 – The latest Innovations in arrhythmia care and technology
Dr Andrew Krahn, President, Heart Rhythm Society (HRS), discusses the upcoming Heart Rhythm 2023 meeting (May 19-21, 2023, New Orleans, LA, USA), and the HRX 2023 conference (September 21-23, 2023, in Seattle, WA, USA) hosted by the Heart Rhythm Society (HRS), a non-profit organization dedicated to improving the care of patients with heart rhythm disorders […]
Transcatheter Mitral Valve Replacement in Patients with Mitral Annular Calcification: A Review
Heart International. 2023;17(1):19–26 DOI: https://doi.org/10.17925/HI.2023.17.1.19
Mitral valve (MV) disease includes either mitral regurgitation or mitral stenosis or both. The incidence and prevalence of valvular heart disease is increasing with the increasing population age. Degenerative MV disease poses a global burden with a prevalence of 18.1 million cases in 2017. Further, its global prevalence increased by 94% from 1990 to 2017.1 Surgery is the gold standard of […]
Steven Messe, TCT 2022: Sentinel® cerebral protection system efficacy in reducing all stroke/disabling stroke, the PROTECTED-TAVR trial (a neurologist’s perspective)
The PROTECTED-TAVR trial studied the efficacy of using an embolic protection device (Sentinel® cerebral protection system) during transcatheter aortic valve replacement in reducing the incidence of stroke/disabling stroke. In this touchCARDIO interview, we speak with Dr Steven Messe (University of Pennsylvania, Philadelphia, PA, USA) to give a Neurologist’s perspective on the findings of the PROTECTED-TAVR […]
Scott Lim, TCT 2022: The PASCAL Transcatheter Valve Repair System in patients with degenerative mitral regurgitation, the CLASP II D trial
The CLASP II D trial aimed to assess the PASCAL Transcatheter Valve Repair System in patients with degenerative mitral regurgitation at risk for surgery. In this touchCARDIO interview, we speak with Dr Scott Lim (The University of Virginia, Charlottesville, VA, USA) to discuss the Edwards PASCAL Transcatheter Valve Repair System and the outcomes of the […]
Antonio Mangieri, TCT 2022: The cutting balloon in patients with calcified lesions, the COPS trial
The COPS trial aimed to assess the use of a cutting balloon technique in patients with calcified lesions. In this touchCARDIO interview, we speak with Dr Antonio Mangieri (Humanitas Research Hospital IRCCS, Rozzano, Milan, Italy) to discuss the challenges in treating patients with coronary artery calcifications and the outcome of the COPS trial. The abstract […]
Riyaz Bashir, TCT 2022: The Bashir endovascular catheter for pulmonary embolism
Mortality remains high in patients with high and intermediate risk pulmonary embolism (PE). The Bashir endovascular catheter device, designed for use in large vessels, aims to improve patient outcomes. In this touchCARDIO interview, we speak with Dr Riyaz Bashir (Temple University Hospital, Philadelphia, PA, USA) to discuss the unmet needs in PE and the Bashir […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!